Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.
about
Review of Factors Related to the Thyroid Cancer Epidemic.Diabetes drugs and the incidence of solid cancers: a survey of the current evidence.Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case-Control (MCC) Study.Prospective serum metabolomic profile of prostate cancer by size and extent of primary tumor.A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus.Identification of a novel 2-oxindole fluorinated derivative as in vivo antitumor agent for prostate cancer acting via AMPK activation.Pleiotropic Effects of Metformin on Cancer
P2860
Q30234328-8044D059-6F65-439C-B192-5631EC1E71DEQ38651175-8DDCCBDB-B797-49C1-B1D2-06B9A64AAD04Q40075959-A7B7B637-5F18-49B4-9027-BA448EB4C253Q40236248-6A27B43F-1F26-4E58-A0F2-6BF190FCBD11Q49884540-F24A8A2E-FC1D-4CC2-ACAA-FB1DC4D8C62FQ52659506-8433C43F-84EF-4D05-BB37-A521D415686CQ59138314-CF99A73B-58DD-4194-AC65-699BB5BA01CF
P2860
Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prospective study of Type 2 di ...... s and risk of prostate cancer.
@en
Prospective study of Type 2 di ...... s and risk of prostate cancer.
@nl
type
label
Prospective study of Type 2 di ...... s and risk of prostate cancer.
@en
Prospective study of Type 2 di ...... s and risk of prostate cancer.
@nl
prefLabel
Prospective study of Type 2 di ...... s and risk of prostate cancer.
@en
Prospective study of Type 2 di ...... s and risk of prostate cancer.
@nl
P2093
P2860
P50
P356
P1476
Prospective study of Type 2 di ...... s and risk of prostate cancer.
@en
P2093
Birgitta Grundmark
David Robinson
Pär Stattin
P2860
P304
P356
10.1002/IJC.30480
P50
P577
2016-10-22T00:00:00Z